SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-20-012341
Filing Date
2020-06-03
Accepted
2020-06-03 16:06:22
Documents
8
Period of Report
2020-06-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cbli20200602_8k.htm 8-K 34781
2 EXHIBIT 4.1 ex_188862.htm EX-4.1 102373
3 EXHIBIT 4.2 ex_188942.htm EX-4.2 107592
4 EXHIBIT 5.1 ex_188863.htm EX-5.1 33594
5 EXHIBIT 10.1 ex_188864.htm EX-10.1 218803
6 EXHIBIT 99.1 ex_188961.htm EX-99.1 13625
7 EXHIBIT 99.2 ex_188971.htm EX-99.2 13105
8 mwlogo01.jpg GRAPHIC 11639
  Complete submission text file 0001437749-20-012341.txt   541079
Mailing Address 73 HIGH STREET BUFFALO NY 14203
Business Address 73 HIGH STREET BUFFALO NY 14203 (716) 849-6810
CLEVELAND BIOLABS INC (Filer) CIK: 0001318641 (see all company filings)

IRS No.: 200077155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32954 | Film No.: 20940030
SIC: 8731 Services-Commercial Physical & Biological Research